169 related articles for article (PubMed ID: 27277421)
1. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
[TBL] [Abstract][Full Text] [Related]
2. Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014).
Lazarus JV; Mozalevskis A; Safreed-Harmon K; Eramova I
Hepatol Med Policy; 2016; 1():3. PubMed ID: 30288307
[TBL] [Abstract][Full Text] [Related]
3. Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey.
Spina A; Eramova I; Lazarus JV
BMC Infect Dis; 2014; 14 Suppl 6(Suppl 6):S15. PubMed ID: 25252705
[TBL] [Abstract][Full Text] [Related]
4. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.
Hatzakis A; Wait S; Bruix J; Buti M; Carballo M; Cavaleri M; Colombo M; Delarocque-Astagneau E; Dusheiko G; Esmat G; Esteban R; Goldberg D; Gore C; Lok AS; Manns M; Marcellin P; Papatheodoridis G; Peterle A; Prati D; Piorkowsky N; Rizzetto M; Roudot-Thoraval F; Soriano V; Thomas HC; Thursz M; Valla D; van Damme P; Veldhuijzen IK; Wedemeyer H; Wiessing L; Zanetti AR; Janssen HL
J Viral Hepat; 2011 Sep; 18 Suppl 1():1-16. PubMed ID: 21824223
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.
Falla AM; Hofstraat SHI; Duffell E; Hahné SJM; Tavoschi L; Veldhuijzen IK
BMC Infect Dis; 2018 Feb; 18(1):79. PubMed ID: 29433454
[TBL] [Abstract][Full Text] [Related]
6. Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009.
Duffell EF; van de Laar MJ
Euro Surveill; 2015 Apr; 20(13):17-24. PubMed ID: 25860392
[TBL] [Abstract][Full Text] [Related]
7. Surveillance and epidemiology of hepatitis B and C in Europe - a review.
Rantala M; van de Laar MJ
Euro Surveill; 2008 May; 13(21):. PubMed ID: 18761967
[TBL] [Abstract][Full Text] [Related]
8. Towards elimination of hepatitis B and C in European Union and European Economic Area countries: monitoring the World Health Organization's global health sector strategy core indicators and scaling up key interventions.
Duffell EF; Hedrich D; Mardh O; Mozalevskis A
Euro Surveill; 2017 Mar; 22(9):. PubMed ID: 28277217
[TBL] [Abstract][Full Text] [Related]
9. Impact of hepatitis B vaccination on acute hepatitis B epidemiology in European Union/European Economic Area countries, 2006 to 2014.
Miglietta A; Quinten C; Lopalco PL; Duffell E
Euro Surveill; 2018 Feb; 23(6):. PubMed ID: 29439751
[TBL] [Abstract][Full Text] [Related]
10. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.
Lazarus JV; Sperle I; Spina A; Rockstroh JK
Croat Med J; 2016 Oct; 57(5):442-456. PubMed ID: 27815935
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015.
Aspinall EJ; Couturier E; Faber M; Said B; Ijaz S; Tavoschi L; Takkinen J; Adlhoch C;
Euro Surveill; 2017 Jun; 22(26):. PubMed ID: 28681720
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.
Mason LMK; Veldhuijzen IK; Duffell E; van Ahee A; Bunge EM; Amato-Gauci AJ; Tavoschi L
J Viral Hepat; 2019 Dec; 26(12):1431-1453. PubMed ID: 31332919
[TBL] [Abstract][Full Text] [Related]
13. Standardising surveillance of hepatitis E virus infection in the EU/EEA: A review of national practices and suggestions for the way forward.
Adlhoch C; Manďáková Z; Ethelberg S; Epštein J; Rimhanen-Finne R; Figoni J; Baylis SA; Faber M; Mellou K; Murphy N; O'Gorman J; Tosti ME; Ciccaglione AR; Hofhuis A; Zaaijer H; Lange H; de Sousa R; Avellón A; Sundqvist L; Said B; Ijaz S
J Clin Virol; 2019 Nov; 120():63-67. PubMed ID: 31590112
[TBL] [Abstract][Full Text] [Related]
14. Estimating hepatitis B virus prevalence among key population groups for European Union and European Economic Area countries and the United Kingdom: a modelling study.
Trickey A; Bivegete S; Duffell E; McNaughton AL; Nerlander L; Walker JG; Fraser H; Hickman M; Vickerman P; Brooks-Pollock E; Christensen H
BMC Infect Dis; 2023 Jul; 23(1):457. PubMed ID: 37430220
[TBL] [Abstract][Full Text] [Related]
15. Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ; Hutchinson SJ; Goldberg DJ; Valerio H; Mozalevskis A; Noori T; Duffell E; Tavoschi L
HIV Med; 2018 Feb; 19 Suppl 1():11-15. PubMed ID: 29488708
[TBL] [Abstract][Full Text] [Related]
16. Healthcare-associated hepatitis B and C transmission to patients in the EU/EEA and UK: a systematic review of reported outbreaks between 2006 and 2021.
Singh J; Stoitsova S; Zakrzewska K; Henszel L; Rosińska M; Duffell E
BMC Public Health; 2022 Dec; 22(1):2260. PubMed ID: 36463162
[TBL] [Abstract][Full Text] [Related]
17. Improving preparedness to respond to cross-border hepatitis A outbreaks in the European Union/European Economic Area: towards comparable sequencing of hepatitis A virus.
Enkirch T; Severi E; Vennema H; Thornton L; Dean J; Borg ML; Ciccaglione AR; Bruni R; Christova I; Ngui SL; Balogun K; Němeček V; Kontio M; Takács M; Hettmann A; Korotinska R; Löve A; Avellón A; Muñoz-Chimeno M; de Sousa R; Janta D; Epštein J; Klamer S; Suin V; Aberle SW; Holzmann H; Mellou K; Ederth JL; Sundqvist L; Roque-Afonso AM; Filipović SK; Poljak M; Vold L; Stene-Johansen K; Midgley S; Fischer TK; Faber M; Wenzel JJ; Takkinen J; Leitmeyer K
Euro Surveill; 2019 Jul; 24(28):. PubMed ID: 31311618
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action.
Nakitanda AO; Montanari L; Tavoschi L; Mozalevskis A; Duffell E
BMC Public Health; 2020 Nov; 20(1):1670. PubMed ID: 33167912
[TBL] [Abstract][Full Text] [Related]
19. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
[TBL] [Abstract][Full Text] [Related]
20. Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.
Falla AM; Ahmad AA; Duffell E; Noori T; Veldhuijzen IK
BMC Infect Dis; 2018 Jan; 18(1):42. PubMed ID: 29338702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
